0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Medical News & Perspectives | 
Julie A. Jacob, MA
JAMA. 2016;315(24):2653-2654. doi:10.1001/jama.2016.6295.

Editorial | 
Deborah Schrag, MD, MPH
JAMA. 2016;315(17):1837-1838. doi:10.1001/jama.2016.4284.

Original Investigation | 
Pascal Hammel, MD; Florence Huguet, MD; Jean-Luc van Laethem, MD; et al.
JAMA. 2016;315(17):1844-1853. doi:10.1001/jama.2016.4324.
Includes: Supplemental Content

Review | 
Alexander Stark, MD; Timothy R. Donahue, MD; Howard A. Reber, MD; et al.
JAMA. 2016;315(17):1882-1893. doi:10.1001/jama.2016.4690.
Includes: CME, Supplemental Content

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2015;314(21):2227. doi:10.1001/jama.2015.16166.

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2014;312(17):1729. doi:10.1001/jama.2014.14889.

Editorial | 
Donald J. Buchsbaum, PhD; Carlo M. Croce, MD
JAMA. 2014;311(4):363-365. doi:10.1001/jama.2013.284665.

Preliminary Communication |  FREE
Nicolai A. Schultz, MD, PhD; Christian Dehlendorff, PhD; Benny V. Jensen, MD; et al.
JAMA. 2014;311(4):392-404. doi:10.1001/jama.2013.284664.
Includes: Supplemental Content

Original Investigation |  FREE
Helmut Oettle, MD, PhD; Peter Neuhaus, MD, PhD; Andreas Hochhaus, MD, PhD; et al.
JAMA. 2013;310(14):1473-1481. doi:10.1001/jama.2013.279201.

Medical News and Perspectives | 
M. J. Friedrich
JAMA. 2011;306(18):1966-1967. doi:10.1001/jama.2011.1624.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Surgery
Invited Commentary  | 
Borderline Resectable Pancreatic Cancer Answering the Most Important Question First
John A. Windsor, MD, FRACS
JAMA Surgery
Original Investigation  | 
Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer Alliance for Clinical Trials in Oncology Trial A021101
Matthew H. G. Katz, MD; Qian Shi, PhD; Syed A. Ahmad, MD; et al.
JAMA Surgery
Review  | 
Therapeutic Advances in Localized Pancreatic Cancer
Susan Tsai, MD, MHS; Douglas B. Evans, MD
JAMA Oncology
Review  | 
Evaluation of Pancreatic Cancer Clinical Trials and Benchmarks for Clinically Meaningful Future Trials A Systematic Review
Lola Rahib, PhD; Julie M. Fleshman, JD, MBA; Lynn M. Matrisian, PhD, MBA; et al.